Cureglim MP 1 Tablet ER
Marketer
Curega Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Cureglim MP 1 Tablet ER
Glimco MP 1 Extended-Release Tablet is a dual-action medication designed to manage blood glucose. This medication, used alongside a healthy diet and regular exercise, enhances blood sugar regulation in adult patients with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Glimco MP 1 ER Tablets. Ingestion with food is recommended to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. An overdose can result in dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or missed meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function assessments will be conducted by your doctor before initiating this therapy. Limit alcohol consumption while taking this medication to reduce the likelihood of adverse reactions.
Uses of Cureglim MP 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Cureglim MP 1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Cureglim MP 1 Tablet ER with a meal.
Common Side effects of Cureglim MP 1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Cureglim MP 1 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Cureglim MP 1 Tablet ER with food.
How Cureglim MP 1 Tablet ER works:
Cureglim MP 1 Extended-Release tablet combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cureglim MP 1 Tablet ER and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Cureglim MP 1 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Cureglim MP 1 Tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, potentially harming the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with impaired kidney function should use Cureglim MP 1 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function assessments are recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Cureglim MP 1 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician for guidance. Cureglim MP 1 Tablet ER is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Cureglim MP 1 Tablet ER :
Should you forget a dose of Cureglim MP 1 Tablet ER, take it immediately if feasible. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Cureglim MP 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


